Free Trial
NASDAQ:BIOR

Biora Therapeutics (BIOR) Stock Price, News & Analysis

Biora Therapeutics logo
$0.13 0.00 (0.00%)
As of 04/25/2025

About Biora Therapeutics Stock (NASDAQ:BIOR)

Key Stats

Today's Range
$0.13
$0.15
50-Day Range
$0.11
$0.17
52-Week Range
$0.15
$7.90
Volume
6,240 shs
Average Volume
65,539 shs
Market Capitalization
$587,990.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.00
Consensus Rating
Buy

Company Overview

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Receive BIOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BIOR Stock News Headlines

Biora Therapeutics Successfully Completes Restructuring Process
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Firm Retention Summary: Biora Therapeutics
Biora Therapeutics undertakes Chapter 11 sales process
See More Headlines

BIOR Stock Analysis - Frequently Asked Questions

Biora Therapeutics' stock was trading at $0.22 at the beginning of 2025. Since then, BIOR shares have decreased by 40.9% and is now trading at $0.13.
View the best growth stocks for 2025 here
.

Biora Therapeutics, Inc. (NASDAQ:BIOR) posted its earnings results on Wednesday, November, 10th. The company reported ($4.60) earnings per share for the quarter, topping analysts' consensus estimates of ($4.70) by $0.10. The business earned $0.18 million during the quarter, compared to analysts' expectations of $11.10 million.

Shares of Biora Therapeutics reverse split before market open on Tuesday, January 3rd 2023. The 1-25 reverse split was announced on Tuesday, January 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of BIOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biora Therapeutics investors own include AMC Entertainment (AMC), Digital World Acquisition (DWAC), NIO (NIO), Meta Platforms (META), NVIDIA (NVDA), Bank of America (BAC) and Ford Motor (F).

Company Calendar

Last Earnings
11/10/2021
Today
4/28/2025
Next Earnings (Estimated)
4/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BIOR
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+17,592.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-124,110,000.00
Pretax Margin
-4,005.83%

Debt

Sales & Book Value

Annual Sales
$892,000.00
Price / Cash Flow
N/A
Book Value
($36.43) per share
Price / Book
0.00

Miscellaneous

Free Float
2,213,000
Market Cap
$587,990.00
Optionable
Optionable
Beta
1.12
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BIOR) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners